Alteration in ovarian gene expression in response to 2,3,7,8-tetrachlorodibenzo- p-dioxin: reduction of cyclooxygenase-2 in the blockage of ovulation

• Published in: Reproductive toxicology (Elmsford, N.Y.) Vol. 16; no. 3; pp. 299 - 307
• Main Authors: Mizuyachi, Kaori, Son, Deok-Soo, Rozman, Karl K, Terranova, Paul F
• Format: Journal Article
• Language: English
• Published: New York, NY Elsevier Inc 01-05-2002; Elsevier
• Subjects: Administration, Oral; AhR; Animals; Biological and medical sciences; Chemical and industrial products toxicology. Toxic occupational diseases; Chorionic Gonadotropin - pharmacology; COX-2; Cyclooxygenase 1; Cyclooxygenase 2; CYP1A1; Cytochrome P-450 CYP1A1 - biosynthesis; Environmental Pollutants - administration & dosage; Environmental Pollutants - toxicity; Estradiol - blood; Female; Gene Expression Regulation, Developmental; Granulosa cell; Immature rat; Isoenzymes - biosynthesis; Isoenzymes - genetics; Medical sciences; Membrane Proteins; Ovary; Ovary - drug effects; Ovary - enzymology; Ovulation; Ovulation - drug effects; Ovulation - metabolism; Plasminogen Activators - metabolism; Plasminogen Inactivators - metabolism; Polychlorinated Dibenzodioxins - administration & dosage; Polychlorinated Dibenzodioxins - toxicity; Prostaglandin-Endoperoxide Synthases - biosynthesis; Prostaglandin-Endoperoxide Synthases - genetics; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid - metabolism; Ribosomal Proteins - biosynthesis; Ribosomal Proteins - genetics; RNA, Messenger - metabolism; Sexual Maturation; Signal Transduction; TCDD; Toxicology; Transcription Factors - metabolism; Various organic compounds; Ovary; Granulosa cell; COX-2; Immature rat; TCDD; CYP1A1; AhR; Ovulation; Prostaglandin-endoperoxide synthase; Reproduction diseases; Rat; Enzyme; Toxicity; Rodentia; Oral administration; Endocrine disruptor; Female genital diseases; Signal transduction; Vertebrata; Mammalia; Impuberal animal; Gene; Oxidoreductases; Mechanism of action
• DOI: 10.1016/S0890-6238(02)00024-2
• EISSN: 1873-1708
• ISSN: 0890-6238

2,3,7,8-Tetrachlorodibenzo-
p-dioxin (TCDD) is a reproductive toxicant and endocrine disrupter that is known to block ovulation. This study was designed to investigate alterations in relevant ovarian genes that may be involved in the blockage of ovulation by TCDD in immature intact rats primed with equine chorionic gonadotropin (eCG). In this ovulation model, rats were given either 32
μg/kg TCDD or corn oil by gavage on 25
days of age. The next day, eCG (5
IU) was injected subcutaneously (s.c.) to stimulate follicular development. Ovulation occurs 72
h after administration of eCG in controls of this model. TCDD blocked ovulation at the expected time and also reduced both ovarian and body weights. At 72
h after eCG (the morning after expected ovulation), TCDD did not alter significantly serum concentrations of progesterone (P4) and androstenedione (A4). However, estradiol (E2) was significantly higher at 72
h after eCG in TCDD-treated rats when compared with controls. Western blots revealed that ovarian CYP1A1 was induced by TCDD. In addition, the aryl hydrocarbon receptor (AhR) and AhR nuclear translocator (ARNT) were down- and up-regulated by TCDD, respectively, indicating that AhR-mediated signal transduction was altered in the ovary. Ovarian estrogen receptor (ER)α, ERβ and progesterone receptor (PR) were not altered significantly by TCDD, but ovarian glucocorticoid receptor (GR) was increased at 24
h after TCDD and decreased at 72
h after eCG when compared with controls. TCDD induced the early appearance of ovarian plasminogen activator inhibitor type-1 (PAI-1), plasminogen activator inhibitor type-2 (PAI-2), urokinase plasminogen activator (uPA), and tissue plasminogen activator (tPA) at 24
h after dosing when compared with controls. On the morning after ovulation (72
h after eCG), no significant differences between control and TCDD-treated rats were observed except that TCDD had still increased tPA and decreased PAI-2 when compared with controls. Interestingly, ovarian COX-2 was induced on the morning after ovulation (72
h after eCG) in controls, but was greatly inhibited in TCDD-treated rats at that time. On the other hand, COX-1 was constitutively expressed throughout the ovulatory period and remained unaffected by TCDD. Immunolocalization of COX-2 in the ovary revealed that TCDD inhibited COX-2 expression in the granulosa cell layer when assessed in the morning of expected ovulation. In conclusion, AhR signaling is activated in the ovary by TCDD and inhibition of COX-2 appeared to be a critical step in the TCDD blockage of ovulation because blockage or reduction of COX-2 expression is well known to be associated with failure of ovulation.